BioMarin Pharmaceutical, Inc. (BMRN)

62.62 -0.30 (-0.48%) USD  |  NASDAQ  |  Feb 24, 16:00
62.95 +0.33 (+0.53%) Pre-Market: 08:58
More

BioMarin Pharmaceutical Operating Income (TTM)

Operating Income (TTM) Chart

View Operating Income (TTM) for BMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (TTM) Range, Past 5 Years

View Operating Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (TTM) Benchmarks

View Operating Income (TTM) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Merck & Co., Inc. Upgrade
AbbVie, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade